Cargando…

Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease

Detalles Bibliográficos
Autor principal:	Yu, Jung Hwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160342/ https://www.ncbi.nlm.nih.gov/pubmed/32192316 http://dx.doi.org/10.3350/cmh.2020.0048

Ejemplares similares

Does limited expression of toll-like receptor 9 actually contribute to T cell activation and liver damage in nonalcoholic steatohepatitis?
por: Eun, Hyuk Soo
Publicado: (2020)

Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
por: Alegre, Nadia Soledad, et al.
Publicado: (2020)

Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease
por: Miura, Kouichi, et al.
Publicado: (2010)

The Roles of the Gut Microbiota and Toll-like Receptors in Obesity and Nonalcoholic Fatty Liver Disease
por: Miura, Kouichi, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease: Role of Medical Colleges in its Prevention and Control
por: Nath, Bhola, et al.
Publicado: (2022)

The significance of Toll-like receptor (TLR) 2 and 9 gene polymorphisms in psoriasis
por: Zabłotna, Monika, et al.
Publicado: (2017)

Importance of Variables in Nonalcoholic Fatty Liver Disease Patients
por: Garg, Vivek Kumar, et al.
Publicado: (2018)

Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Pratap, Abhijit, et al.
Publicado: (2023)

Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Li, Xia, et al.
Publicado: (2018)

Toll like receptors: Sensors for herpes simplex virus infection
por: Govindan, Balaji
Publicado: (2014)

Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Bibbò, Stefano, et al.
Publicado: (2018)

Comments to Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Guan, Yong-Song
Publicado: (2014)

Relationship between nonalcoholic fatty liver disease and chronic kidney disease could start in childhood
por: Di Sessa, Anna, et al.
Publicado: (2021)

Aspirin inhibited the metastasis of colon cancer cells by inhibiting the expression of toll-like receptor 4
por: Kagbo-Kue, Suaka, et al.
Publicado: (2018)

The Importance of Visceral Adipose Tissue Detected by Imaging Methods to Assess Nonalcoholic Fatty Liver Disease Properly
por: Ozcelik, Fatih, et al.
Publicado: (2021)

No Association Between Nonalcoholic Fatty Liver Disease and Severe COVID-19? Something We Might Ignore
por: Gao, Hui, et al.
Publicado: (2022)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease—Ex Vivo Studies
por: Zwolak, Agnieszka, et al.
Publicado: (2016)

Toll-like receptors, innate immune system, and lung diseases: a vital trilateral association
por: Patel, Vyoma K., et al.
Publicado: (2022)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Beyond the boundaries of the liver
por: Gupta, Tarana
Publicado: (2022)

Nuclear Receptors in Nonalcoholic Fatty Liver Disease
por: López-Velázquez, Jorge A., et al.
Publicado: (2012)

Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity
por: Videla, Luis A., et al.
Publicado: (2012)

Saturated Fatty Acid Inhibits Viral Replication in Chronic Hepatitis B Virus Infection With Nonalcoholic Fatty Liver Disease by Toll-Like Receptor 4-Mediated Innate Immune Response
por: Zhang, Rui-Nan, et al.
Publicado: (2015)

Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
por: Liu, Yuanbin, et al.
Publicado: (2023)

Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease
por: Chen, Wei, et al.
Publicado: (2018)

Toll-Like Receptor 9 in Breast Cancer
por: Sandholm, Jouko, et al.
Publicado: (2014)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease
por: Kim, Sokho, et al.
Publicado: (2016)

Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression
por: Ahn, Hwa Young, et al.
Publicado: (2018)

COVID-19 Morbidity and Severity in Patients With Nonalcoholic Fatty Liver Disease in South Korea: A Nationwide Cohort Study
por: Yoo, Hae Won, et al.
Publicado: (2022)

Chemoproteomics reveals Toll-like receptor fatty acylation
por: Chesarino, Nicholas M, et al.
Publicado: (2014)

Intestinal virome: An important research direction for alcoholic and nonalcoholic liver diseases
por: Li, Yan, et al.
Publicado: (2022)

Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
por: Lee, Seung Min, et al.
Publicado: (2023)

Duodenal Niemann-Pick C1-like 1 expression was negatively correlated with liver X receptor expression in nonalcoholic fatty liver disease
por: Ahn, Sang Bong, et al.
Publicado: (2019)

Surface toll-like receptor 9 on immune cells and its immunomodulatory effect
por: Kou, Mengyuan, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
por: El Ouaamari, Abdelfattah, et al.
Publicado: (2013)

Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Baek, Jung-Hwan, et al.
Publicado: (2023)

Toll-Like Receptor 3 in Liver Diseases
por: Yin, Shi, et al.
Publicado: (2010)

Toll-Like Receptor Signaling in Liver Diseases
por: Szabo, Gyongyi, et al.
Publicado: (2010)

Toll-Like Receptor Signaling and Liver Fibrosis
por: Aoyama, Tomonori, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ig017vq1r2uijb7ipfq9skue45